These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Stanley CA Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304 [TBL] [Abstract][Full Text] [Related]
4. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999 [TBL] [Abstract][Full Text] [Related]
5. Dissecting the spectrum of fatty acid oxidation disorders. Stanley CA J Pediatr; 1998 Mar; 132(3 Pt 1):384-6. PubMed ID: 9544886 [No Abstract] [Full Text] [Related]
6. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508 [TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism. Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643 [TBL] [Abstract][Full Text] [Related]
8. Role of carnitine-dependent metabolic pathways in heart disease without primary ischemia. Bremer J; Hokland B Z Kardiol; 1987; 76 Suppl 5():9-13. PubMed ID: 3324530 [TBL] [Abstract][Full Text] [Related]
9. [Carnitine deficiency in inborn errors of metabolism]. Sela BA; Lerman-Sagie T; Berkovitz M Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309 [TBL] [Abstract][Full Text] [Related]
10. Urinary acylcarnitines in a patient with neonatal multiple acyl-CoA dehydrogenation deficiency, quantified by a carboxylic acid analyzer with a reversed-phase column. Kidouchi K; Niwa T; Nohara D; Asai K; Sugiyama N; Morishita H; Kobayashi M; Wada Y Clin Chim Acta; 1988 Apr; 173(3):263-72. PubMed ID: 3383426 [TBL] [Abstract][Full Text] [Related]
14. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders. Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014 [TBL] [Abstract][Full Text] [Related]
15. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222 [TBL] [Abstract][Full Text] [Related]
16. Reye syndrome versus defects in oxidation of fatty acids. Wilson BE; Anderson LW J Pediatr; 1986 Jan; 108(1):159. PubMed ID: 3944684 [No Abstract] [Full Text] [Related]
17. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency. Rinaldo P; Schmidt-Sommerfeld E; Posca AP; Heales SJ; Woolf DA; Leonard JV J Pediatr; 1993 Apr; 122(4):580-4. PubMed ID: 8463904 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial β-oxidation of saturated fatty acids in humans. Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309 [TBL] [Abstract][Full Text] [Related]
19. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects. Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847 [No Abstract] [Full Text] [Related]